Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First and only TIGIT/TGF-β dual-targeting antibody fusion protein of Akeso demonstrated promise in preclinical results published at ESMO 2022-09-13 14:02
SeekIn Receives CE Mark Approval for OncoSeek® Multi-Cancer Detection Test 2022-09-12 21:37
Origin Agritech Announces Addition to Two FTSE Russell Equity Indices 2022-09-12 20:45
I-Mab Announces Positive Phase 2 Data of Lemzoparlimab in Combination with Azacitidine (AZA) in Patients with Higher Risk Myelodysplastic Syndrome at ESMO 2022 2022-09-10 21:00
Redbud raises $10M in series A round as CRO focusing on science-driven clinical development 2022-09-10 05:13
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers 2022-09-09 20:00
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company 2022-09-09 17:53
Waterdrop Inc. Announces Second Quarter 2022 Unaudited Financial Results 2022-09-09 16:00
Antengene to Present at Upcoming Industry Conferences 2022-09-09 14:43
Pulnovo Medical Concludes Successfully the First Steering Committee Meeting 2022-09-08 20:30
InxMed Announces First Patient Dosed in Phase 2 Pivotal Study of IN10018 In Patients with Platinum-Resistant Recurrent Ovarian Cancer 2022-09-08 08:00
Biosion, Inc. Appoints Dr. Rakesh Dixit, ADC Thought Leader, to Advisory Board 2022-09-07 20:54
Lianhua Products Designated as Epidemic Prevention Supplies : 2022 CIFTIS 2022-09-07 20:15
Tycoon Group Signs Cooperation Agreement with JD Logistics, Obtains Operating Rights of Logistics Supply Chain Industry Bases in France 2022-09-07 20:13
GenFleet Therapeutics to Present Data from Phase I Trial of GFH018 Monotherapy at the 2022 European Society for Medical Oncology Annual Meeting 2022-09-07 19:00
Waterdrop Announces Appointment of a New Director 2022-09-07 16:54
Laekna Announces First Patient Dosed in South Korea in LAE201INT2101 Phase 1/2 Study 2022-09-06 17:02
Jacobio Receives CDE Approval for KRAS G12C Inhibitor JAB-218822's Phase II Pivotal Study in China 2022-09-06 15:20
Dizal Announces Sunvozertinib Meets Primary Endpoint in its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMO 2022-09-05 22:49
Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Breast Cancer at 2022 ESMO 2022-09-05 22:39
1 140 141 142 143 144 801